Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
04:05pm, Thursday, 29'th Apr 2021
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare Confe
Earnings Preview: 10x Genomics (TXG) Q1 Earnings Expected to Decline
01:49pm, Wednesday, 28'th Apr 2021
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan
06:35am, Saturday, 24'th Apr 2021
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit.
3 Hot Healthcare Stocks Cathie Wood Is Buying in April
06:01am, Saturday, 17'th Apr 2021
Here's why she likes them so much.
How 10x Genomics Is Turbocharging Genetic Research
06:04am, Tuesday, 06'th Apr 2021
The company's technology is enabling researchers to explore single cells like never before.
How Genomics Research Could Change How Multiple Sclerosis Is Treated
07:05am, Monday, 05'th Apr 2021
10x Genomics CEO Serge Saxonov thinks we're at the threshold of some big discoveries.
Could 10x Genomics Deliver a 10x Return?
06:04am, Monday, 05'th Apr 2021
The company's CEO thinks it's capitalizing on the biggest value-creation opportunity of the next several decades.
How Can Investors Find Innovative Companies Early?
11:01am, Sunday, 04'th Apr 2021
10x Genomics' CEO identifies three key things to look for.
10x Genomics CEO: Why We're at the Beginning of a Biology Revolution
07:03am, Sunday, 04'th Apr 2021
Several trends are converging.
10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit
08:30am, Thursday, 01'st Apr 2021
Along with recent release of CellPlex, product increases access through affordability Along with recent release of CellPlex, product increases access through affordability
Analysts See Plenty of Potential for 10x Genomics
11:24am, Friday, 26'th Mar 2021
Eighteen months after going public, 10x Genomics Inc.'s (TGX) shares have tripled to more than $166, yet analysts think that's still well below its twelve-month median price target. Some on Wall Stree
Conoco, Dow, Pure Storage, Signet Jewelers and More of Monday Afternoon's Analyst Calls
11:53am, Monday, 15'th Mar 2021
With the trading day nearing halfway over, the broad markets were trading sideways on Monday.
10x Genomics Expands Pleasanton Headquarters with New Facilities at Two Locations
08:30am, Tuesday, 09'th Mar 2021
City to Change Street Name to ‘Genomics Place'
OMX Ventures Adds New Team Members to Expand Investment and Company Creation Activities in $150M Oversubscribed Fund I
08:02am, Tuesday, 02'nd Mar 2021
CHICAGO--(BUSINESS WIRE)--OMX Ventures expands team with addition of Jamie Kasuboski, Ph.D. as Vice President and Kevin Ness, Ph.D. as Fund Advisor.
Baron Perspective- 2020: A Year We Will Remember
06:19pm, Monday, 01'st Mar 2021
2020 was a year that will be hard to forget. The headlines were dominated by the pandemic and its social and economic aftermath, but there were also wildfires, violent social and racial unrest, the U.
